Vivo Capital’s 8th fund to invest in healthcare in US and Greater China
Healthcare investment firm Vivo Capital has held the final closing of Vivo Capital Fund VIII at USD750 million, which brings the firm's total funds under management to more than USD1.7 billion. Vivo plans to invest the capital primarily in later development stage pharmaceutical and medical device companies in the US



